BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11517183)

  • 1. Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice.
    Dutertre M; Gouédard L; Xavier F; Long WQ; di Clemente N; Picard JY; Rey R
    Endocrinology; 2001 Sep; 142(9):4040-6. PubMed ID: 11517183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the anti-müllerian hormone served as a marker for granulosa cell tumor of ovary].
    Long W; Wang W; Rey R
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):356-8. PubMed ID: 11776178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.
    Baarends WM; Uilenbroek JT; Kramer P; Hoogerbrugge JW; van Leeuwen EC; Themmen AP; Grootegoed JA
    Endocrinology; 1995 Nov; 136(11):4951-62. PubMed ID: 7588229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.
    Gouédard L; Chen YG; Thevenet L; Racine C; Borie S; Lamarre I; Josso N; Massague J; di Clemente N
    J Biol Chem; 2000 Sep; 275(36):27973-8. PubMed ID: 10854429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
    Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
    Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
    Anttonen M; Färkkilä A; Tauriala H; Kauppinen M; Maclaughlin DT; Unkila-Kallio L; Bützow R; Heikinheimo M
    Lab Invest; 2011 Nov; 91(11):1605-14. PubMed ID: 21808236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.
    Rey R; Sabourin JC; Venara M; Long WQ; Jaubert F; Zeller WP; Duvillard P; Chemes H; Bidart JM
    Hum Pathol; 2000 Oct; 31(10):1202-8. PubMed ID: 11070112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of anti-Müllerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries.
    Ball BA; Conley AJ; MacLaughlin DT; Grundy SA; Sabeur K; Liu IK
    Theriogenology; 2008 Oct; 70(6):968-77. PubMed ID: 18599114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
    Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
    di Clemente N; Wilson C; Faure E; Boussin L; Carmillo P; Tizard R; Picard JY; Vigier B; Josso N; Cate R
    Mol Endocrinol; 1994 Aug; 8(8):1006-20. PubMed ID: 7997230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptor.
    Dutertre M; Rey R; Porteu A; Josso N; Picard JY
    Mol Cell Endocrinol; 1997 Dec; 136(1):57-65. PubMed ID: 9510068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of anti-Müllerian hormone (amh) and anti-Müllerian hormone receptor type II (amhrII) in the teleost medaka.
    Klüver N; Pfennig F; Pala I; Storch K; Schlieder M; Froschauer A; Gutzeit HO; Schartl M
    Dev Dyn; 2007 Jan; 236(1):271-81. PubMed ID: 17075875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand.
    Salhi I; Cambon-Roques S; Lamarre I; Laune D; Molina F; Pugnière M; Pourquier D; Gutowski M; Picard JY; Xavier F; Pèlegrin A; Navarro-Teulon I
    Biochem J; 2004 May; 379(Pt 3):785-93. PubMed ID: 14750901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and clinical significance of anti-Müllerian hormone determination in blood serum of the mare.
    Almeida J; Ball BA; Conley AJ; Place NJ; Liu IK; Scholtz EL; Mathewson L; Stanley SD; Moeller BC
    Theriogenology; 2011 Nov; 76(8):1393-403. PubMed ID: 21798581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertoli Cell-Specific Activation of Transforming Growth Factor Beta Receptor 1 Leads to Testicular Granulosa Cell Tumor Formation.
    Fang X; Nie L; Putluri S; Ni N; Bartholin L; Li Q
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High specificity of Müllerian-inhibiting substance signaling in vivo.
    Mishina Y; Whitworth DJ; Racine C; Behringer RR
    Endocrinology; 1999 May; 140(5):2084-8. PubMed ID: 10218958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal recessive segregation of a truncating mutation of anti-Müllerian type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro.
    Messika-Zeitoun L; Gouédard L; Belville C; Dutertre M; Lins L; Imbeaud S; Hughes IA; Picard JY; Josso N; di Clemente N
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4390-7. PubMed ID: 11549681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ovarian function: the role of anti-Müllerian hormone.
    Durlinger AL; Visser JA; Themmen AP
    Reproduction; 2002 Nov; 124(5):601-9. PubMed ID: 12416998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.